Robert received his B.S in biology from Rider University and his Ph.D. in Immunology and Microbial Pathogenesis from Thomas Jefferson University studying the link between autoimmunity and cancer. He is currently a Scientific Director in the Translational Sciences group within Immunologix Laboratories. Prior to this role, he spent 13 years at Bristol Myers Squibb (BMS). At BMS, he advanced through roles of increasing responsibility to become a Senior Research Investigator in the Bioanalytical Sciences department where he led a group of scientists focused on the analysis of protein biomarkers used in clinical research across the company’s portfolio, with a focus on multiplex analysis. His efforts on ligand binding assays have been applied across the drug development spectrum. Leaving the bioanalytical department, he then transitioned to a role as an associate director in the Pharmacodiagnostics group where he supported the development and execution of the biomarker diagnostic programs for the product development and brand teams. Outside of BMS he is a member of a number of professional societies, including the American Association of Pharmaceutical Sciences, the Regulatory Affairs Professionals Society, and the American Association of Immunologists. In these roles he has been an active member of the biomarkers and precision medicine community group, as well as the bioanalytical community group.